Back
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Buy
71
GVUS
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF
Last Price:
$54.15
Seasonality Move:
1.15%
Sell
40
ORKA
Oruka Therapeutics, Inc.
Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
71
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF (GVUS)
is a Buy
Is Goldman Sachs MarketBeta Russell 1000 Value Eq ETF a Buy, Sell or Hold?
-
The current Goldman Sachs MarketBeta Russell 1000 Value Eq ETF [GVUS] share price is $54.58. The Score for GVUS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
GVUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GVUS Stock Price Chart
What is Goldman Sachs MarketBeta Russell 1000 Value Eq ETF's stock price today?
-
The Goldman Sachs MarketBeta Russell 1000 Value Eq ETF share price today is $54.58The current trend is moderately bullish and GVUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $31.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.
GVUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 62.01 | Buy |
| Chaikin Money Flow: | 421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.58 - 54.42) | Buy |
| Bollinger Bands (100): | (51.19 - 53.41) | Buy |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 61.53 | Buy |
| Chaikin Money Flow: | 394649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.23 - 31.09) | Buy |
| Bollinger Bands (100): | (15.89 - 28.91) | Buy |
GVUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.26 | Buy |
| 20-day SMA: | 53.91 | Buy |
| 50-day SMA: | 53.03 | Buy |
| 200-day SMA: | 50.33 | Buy |
| 8-day EMA: | 54.18 | Buy |
| 20-day EMA: | 53.84 | Buy |
| 50-day EMA: | 53.17 | Buy |
| 200-day EMA: | 51.04 | Buy |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.97 | Buy |
| 20-day SMA: | 30.06 | Buy |
| 50-day SMA: | 28.52 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 30.34 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 27.54 | Buy |
| 200-day EMA: | 21.05 | Buy |
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Earnings Growth & GVUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.
Goldman Sachs MarketBeta Russell 1000 Value Eq ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||